50
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Cost of HAART in Italy: multicentric evaluation and determinants from a large HIV outpatient cohort

, , , , , , , , , , , , , , , & show all
Pages 27-35 | Published online: 22 Dec 2014

References

  • MagoniMScarcellaCVassalloFThe evolving burden of HIV infection compared with other chronic diseases in northern ItalyHIV Med20111212913720666848
  • LevyARJamesDJohnstonKMThe direct costs of HIV/AIDS careLancet Infect Dis2006617117716500598
  • SullivanRPeppercornJSikoraKDelivering affordable cancer care in high-income countriesLancet Oncol20111293398021958503
  • SloanCEChampenoisKChoisyPNewer drugs and earlier treatment: impact on lifetime cost of care for HIV-infected adultsAIDS201226455622008655
  • KrentzHBAuldMCGillMJfor the HIV Economic Study GroupThe changing direct costs of medical care for patients with HIV/AIDS, 1995–2001CMAJ200316910611012874156
  • MeritoMBonaccorsiAPammolliFEconomic evaluation of HIV treatments: the ICONA cohort studyHealth Policy20057430431316226140
  • KrentzHBGillJDespite CD4 cell count rebound the higher initial costs of medical care for HIV-infected patients persist 5 years after presentation with CD4 cell counts less than 350 microLAIDS2010242750275320852403
  • RizzardiniGRestelliUBonfantiPThe cost of HIV disease in Northern Italy: the payer’s perspectiveJ Acquir Immune Defic Syndr20115721121721546850
  • CohenMSChenYQMcCauley M, et al; HPTN 052 Study Team. Prevention of HIV-1 infection with early antiretroviral therapyN Engl J Med201136549350521767103
  • Center for Disease Control and PreventionPreexposure prophylaxis for the prevention of HIV infection on the United States 2014 Available from: http://www.cdc.gov/hiv/pdf/PrEPguidelines2014.pdfAccessed June 8, 2014
  • ForemanCGazzardBJohnsonMSharottPCollinsSMaintaining cost-effective access to antiretroviral drug therapy through a collaborative approach to drug procurement, consensus treatment guidelines and regular audit: the experience of London HIV commissioners and providersSex Transm Infect20128811211522345023
  • GazzardBMoecklinghoffCHillANew strategies for lowering the costs of antiretroviral treatment and care for people with HIV/AIDS in the United KingdomClinicoecon Outcomes Res2012419320022888265
  • HellebergMEngsigFNKronborgGRetention in a public healthcare system with free access to treatment: a Danish nationwide HIV cohort studyAIDS20122674174822156974
  • HallHIHalversonJWilsonDPLate diagnosis and entry to care after diagnosis of human immunodeficiency virus infection: a country comparisonPLoS One20138e7776324223724
  • ParrutiGVadiniFSozioFPsychological factors, including alexithymia, in the prediction of cardiovascular risk in HIV infected patients: results of a cohort studyPLoS One20138e5455523349927
  • Cozzi-LepriAProsperiMCKjærJCan linear regression modeling help clinicians in the interpretation of genotypic resistance data? An application to derive a lopinavir-scorePLoS ONE20116e2566522110581
  • TibshiraniRRegression shrinkage and selection via the LassoJ R Stat Soc Series B Stat Methodol199658267288
  • EfronBHastieTJohnstoneITibshiraniRLeast angle regressionAnn Stat200432407499
  • TontodonatiMSozioFVadiniFA multifactorial risk score to evaluate baseline and antiretroviral-related toxicities relative to the costs of current antiretroviral regimens in a cohort of HIV-infected patientsOral communication OC40 presented at the Ninth Italian Conference on AIDS and RetrovirusesJune 10–12, 2012Naples, Italy
  • RizzardiniGRestelliUBonfantiPCost of human immunodeficiency virus infection in Italy, 2007–2009: effective and expensive, are the new drugs worthwhile?Clinicoecon Outcome Res20124245252
  • Oliva-MorenoJLópez-BastidaJSerrano-AguilarPPerestelo-PérezLDeterminants of health care costs of HIV-positive patients in the Canary Island, SpainEur J Health Econ20101140541220049503
  • MostardtSHanhoffNWasemJCost of HIV and determinants of health care costs in HIV-positive patients in Germany: results of the DAGNA K3A StudyEur J Health Econ20131479980822990377
  • FongRChengACVujovicOHoyJFFactors associated with virological failure in a cohort of combination antiretroviral therapy-treated patients managed at a tertiary referral centreSex Health20131044244724119435
  • LapriseCde PokomandyABarilJGDufresneSTrottierHVirologic failure following persistent low-level viremia in a cohort of HIV-positive patients: results from 12 years of observationClin Infect Dis2013571489149623946221
  • KrentzHBAuldMCGillMJThe high cost of medical care for patients who present late (CD4 <200 cells/microL) with HIV infectionHIV Med20045939815012648